Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | METAP2 | P50579 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.53 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 2/20 | 0.49 |
| ▸ | PTPRC | P08575 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18015351 | 0.88 | METAP2 (0.49) | MAOBMETAP2ALOX5GRM4CYP11B1 | |
| SCHEMBL4660662 | 0.84 | METAP2 (0.49) | MAOBMETAP2ALOX5GRM4CYP11B1 | |
| SCHEMBL4660876 | 0.83 | NPC1 (0.49) | MAOBMETAP2ALOX5GRM4CYP11B1 | |
| SCHEMBL21462499 | 0.82 | MAOB (0.54) | MAOBMETAP2ALOX5GRM4NPC1 | |
| SCHEMBL21472147 | 0.82 | MAOB (0.54) | MAOBMETAP2ALOX5GRM4NPC1 | |
| SCHEMBL3687210 | 0.82 | MAOB (0.54) | MAOBMETAP2ALOX5GRM4NPC1 | |
| SCHEMBL13201325 | 0.82 | GRM4 (0.59) | MAOBMETAP2GRM4CYP11B1NPC1 | |
| SCHEMBL4660617 | 0.82 | MAOB (0.58) | MAOBMETAP2GRM4CYP11B1NPC1 | |
| SCHEMBL21462312 | 0.79 | MAOB (0.54) | MAOBMETAP2ALOX5GRM4NPC1 | |
| SCHEMBL2596508 | 0.78 | HDAC6 (0.59) | MAOBMETAP2ALOX5NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1244155-B1 | Metal coordination compound, luminescence device and display apparatus | CANON KK (JP) | 2008-12-17 | — | — | EP | disclosed |
| US-6869694-B2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2005-03-22 | — | — | US | disclosed |
| US-20050027123-A1 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2005-02-03 | — | — | US | disclosed |
| US-20030085646-A1 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2003-05-08 | — | — | US | disclosed |
| EP-1244155-A2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050027123-A1 | Metal coordination compound, luminescence device and display apparatus | MCOLN2, CCNL2, MCM2 | MAOB 2176/4885METAP2 1195/4885ALOX5 1544/4885 |
| US-20030085646-A1 | Metal coordination compound, luminescence device and display apparatus | CYC1, CCNL2, LEF1 | MAOB 2141/4885METAP2 1550/4885ALOX5 1808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.